Diagnosing Chronic Pelvic Pain in 2026: New Paradigms

A more useful way to diagnose chronic pelvic pain in 2026 is to see it as a multisystem pain condition rather than a single gynecologic diagnosis. This matters because endometriosis, IC/BPS, IBS, vulvodynia, pudendal neuralgia, and musculoskeletal pain often overlap in the same patient and can reinforce one another.

1. The Shifting Diagnostic Framework

Chronic pelvic pain is generally defined as pain perceived to originate in the pelvis, lasting more than 6 months, and associated with adverse cognitive, behavioral, sexual, or emotional consequences. In practice, the diagnosis is often delayed because symptoms may involve the reproductive tract, bladder, bowel, nerves, vulva, and pelvic floor at the same time.

Historically, clinicians searched for one “main” diagnosis to explain the entire pain picture. The newer model recognizes that CPP is often a regional pain syndrome with overlapping contributors rather than a single isolated disease.

2. The FIGO-IPPS Classification System

One of the most important advances is the FIGO-IPPS “R U MOVVING SOMe” classification system, which organizes chronic pelvic pain into reproductive, urinary, musculoskeletal, neurologic, vascular, vestibular, intestinal, gastrointestinal, systemic, psychological, and metabolic domains. This framework helps clinicians identify multiple active pain generators instead of forcing all symptoms into one organ-based category.

That shift is especially helpful for patients whose pain has been labeled in different ways over time. A patient may carry diagnoses such as endometriosis, IBS, bladder pain syndrome, and vulvodynia simultaneously, yet still have one dominant shared phenotype on examination.

3. The Shared Pelvic Floor Phenotype

A major insight in contemporary CPP care is that many associated diagnoses converge on the same physical finding: a hypertonic, tender pelvic floor. In one key study of urologic chronic pelvic pain syndrome, pelvic floor muscle tenderness was present in about 81% of patients compared with 9% of controls, and greater tenderness was associated with worse pain and poorer quality of life.

This supports the idea that the pelvic floor is often a final common pathway for persistent pain. Repeated nociceptive input from pelvic organs, bowel dysfunction, vulvar pain, or nerve irritation can lead to guarding, trigger points, muscle overactivity, local hypoxia, and chronic tenderness.

4. Endometriosis, Pudendal Neuralgia, IBS, and Vulvodynia

Endometriosis is one of the best examples of why diagnosis has become more nuanced. Even when endometriosis is present, lesion burden alone may not explain symptom severity because ongoing nociceptive input can promote pelvic floor dysfunction and central sensitization. That is one reason patients may continue to report dyspareunia, pressure, bowel pain, or bladder pain after otherwise appropriate medical or surgical therapy.

Pudendal neuralgia can also overlap with pelvic floor dysfunction. Although often described as a neuropathic condition, irritation of the pudendal territory may coexist with deep pelvic muscle tenderness and spasm that perpetuate sitting pain, perineal pain, and referred symptoms.

IBS and vulvodynia fit the same model. Bowel urgency, bloating, painful defecation, introital pain, and vulvar allodynia can all contribute to guarding and poor pelvic floor relaxation, reinforcing a cycle of chronic pelvic pain.

5. Why Diagnosis Matters for Treatment Planning

The value of a modern diagnostic approach is that it changes what is treated first. If approximately 80% of many CPP-associated cohorts demonstrate a hypertonic, tender pelvic floor, then the clinician should not focus only on the disease label, but also on the shared musculoskeletal phenotype driving daily symptoms.

This is why multimodality treatment plans should have, at their foundation, a focus on managing pelvic floor dysfunction. Even when the patient’s associated diagnosis is endometriosis, IC/BPS, IBS, vulvodynia, or pudendal neuralgia, identifying and treating pelvic floor hypertonicity may be central to achieving meaningful relief.

Bibliography

As-Sanie S, Ross WT, Till SR. Evaluation and Treatment of Chronic Pelvic Pain. Obstet Gynecol. 2026;147(1):21-43.

American College of Obstetricians and Gynecologists. Chronic pelvic pain. ACOG Practice Bulletin No. 218. Obstet Gynecol. 2020;135:e98-e109.

Bornstein J, Goldstein AT, Stockdale CK, et al. 2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. Obstet Gynecol. 2016;127:745-751.

Gupta P, Chen J, Kutch JJ, et al. Is Pelvic Floor Muscle Tenderness a Distinct Urologic Chronic Pelvic Pain Syndrome Phenotype? J Urol. 2022;208(2):341-349.

Lamvu G, Carrillo J, Ouyang C, Rapkin A. Chronic pelvic pain in women: a review. JAMA. 2021;325:2381-2391.

Lamvu G, et al. Developing the FIGO-IPPS “R U MOVVING SOMe” classification system for female chronic pelvic pain. Int J Gynecol Obstet. 2025;171:550-565.

Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: implications for diagnosis and classification. J Pain. 2016;17(9 Suppl):T93-T107.